YTHDF2 and ovarian carcinoma: The METTL3/YTHDF2 axis promotes degradation of tumour suppressor IFFO1 mRNA in an m6A-dependent manner to promote nucleation of β-catenin and enhance cisplatin resistance in ovarian cancer [107].